Establishing a Position in the Healthcare Industry through Management Integration with 小西共和ホールディング
First written in FY2016. 3 of 6 entries say "Restated". Latest entry: FY2021.
1 other company's latest entry also says "Restated".
- FY2021RestatedAnnual report
「An absorption-type merger in which 小西医療器株式会社 was the surviving company and 小西共和ホールディング株式会社 and 共和医理器株式会社 were the absorbed companies」
The annual report confirms that the intra-group integration following the management integration with 小西共和ホールディング was carried out as an absorption-type merger. - FY2021-Q3AdvancedAnnual report
「To further improve services for customers by expanding the scale of the business and its business domains, as well as realizing synergies through more efficient management and other measures.」
小西共和ホールディング and 共和医理器 were absorbed into 小西医療器, further giving concrete form to integration and efficiency improvements within the group following the earlier management integration. - FY2017-Q3RestatedAnnual report
「Revenue and profit increased, partly due to the contribution to performance from the management integration with 小西共和ホールディング株式会社.」
The consolidation effects of the management integration continue to contribute to performance. - FY2017-Q2RestatedAnnual report
「Revenue and profit increased, primarily due to contributions from the newly consolidated companies following the management integration with 小西共和ホールディング株式会社.」
The management integration itself was completed in the previous quarter, and this quarter reconfirmed that its consolidation effects contributed to performance. - FY2017-Q1AdvancedAnnual report
「In accordance with the share transfer agreement, the company acquired the common shares of 小西共和HD on 1 April 2016. In accordance with the share exchange agreement, it carried out the share exchange effective 27 April 2016 and made 小西共和HD a wholly owned subsidiary.」
The acquisition of shares in and share exchange with 小西共和ホールディング were completed, resulting in a post-acquisition voting-rights ratio of 100%. - FY2016First statedAnnual report
「The purpose of this management integration is to establish a position as a leader in Japan's healthcare industry by combining the management resources that the two companies have cultivated independently, and to become a company highly valued by all stakeholders.」
A subsequent event involving the acquisition of shares on 1 April 2016 and the conversion into a wholly owned subsidiary through a share exchange on 27 April of the same month. The aim is to integrate human resources, information networks, customer bases and relationships of trust with medical institutions.